cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Bluebird Bio Inc
34 own
36 watching
Current Price
$1.02
$0.07
(7.37%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
117.83M
52-Week High
52-Week High
5.53000
52-Week Low
52-Week Low
0.88000
Average Volume
Average Volume
8.14M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization117.83M
icon52-Week High5.53000
icon52-Week Low0.88000
iconAverage Volume8.14M
iconDividend Yield--
iconP/E Ratio--
What does the Bluebird Bio Inc do?
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic diseases and cancer. Its product candidates include Lenti-D that is in phase II/III clinical studies for the treatment of cerebral adrenoleukodystrophy, a rare hereditary neurological disorder; and LentiGlobin, which is in four clinical studies for the treatment of transfusion-dependent beta-thalassemia, and severe sickle cell disease. The company's lead product candidate is bb2121, a chimeric antigen receptor T cell product candidate that is in Phase I trial for the treatment of relapsed/refractory multiple myeloma. bluebird bio, Inc. has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology; Kite Pharma, Inc. to develop and commercialize second generation T cell receptor (TCR) product candidates against an antigen related to certain cancers associated with the human papilloma virus; and Medigene AG for the research and development of TCR product candidates directed against approximately four antigens for the treatment of cancer indications. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Read More
How much money does Bluebird Bio Inc make?
News & Events about Bluebird Bio Inc.
PR Newswire
10 months ago
Thinking about buying stock in bluebird bio, Uniqure, Terawulf, Metaworks Platforms, or Nikola Corp? Thinking about buying stock in bluebird bio, Uniqure, Terawulf, Metaworks Platforms, or Nikola Corp? PR Newswire NEW YORK, June 21, 2023 NEW YORK, June 21, 2023 /PRNewswire/ -- InvestorsObserver...
PR Newswire
11 months ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUE PR Newswire NEW YORK, May 2, 2023 NEW YORK, May 2, 2023 /PRNewswire...
Globe Newswire
12 months ago
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. (bluebird or the Company) (NASDAQ: BLUE). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
Globe Newswire
1 year ago
NEW YORK, April 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of bluebird bio, Inc. (bluebird or the Company) (NASDAQ: BLUE). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation ...
Ticker Report
1 year ago
bluebird bio (NASDAQ:BLUE Get Rating) and Harpoon Therapeutics (NASDAQ:HARP Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, risk, analyst ...
Frequently Asked Questions
Frequently Asked Questions
What is Bluebird Bio Inc share price today?
plus_minus_icon
Can Indians buy Bluebird Bio Inc shares?
plus_minus_icon
How can I buy Bluebird Bio Inc shares from India?
plus_minus_icon
Can Fractional shares of Bluebird Bio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Bluebird Bio Inc stocks?
plus_minus_icon
What is today’s traded volume of Bluebird Bio Inc?
plus_minus_icon
What is today’s market capitalisation of Bluebird Bio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Bluebird Bio Inc?
plus_minus_icon
What percentage is Bluebird Bio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Bluebird Bio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.02
$0.07
(7.37%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00